Navigation Links
FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment
Date:6/14/2011

p>The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Media Inquiries: Erica Jefferson, 301-796-4988, erica.jefferson@fda.hhs.gov

Consumer Inquiries: 888-INFO-FDA


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... SAN DIEGO , March 5, 2015 /PRNewswire/ ... company engaged in the development of biosimilar therapeutics ... announced today that its fourth quarter and full ... Monday, March 16, 2015, before the market opens ... management will host a conference call to discuss ...
(Date:3/5/2015)... TÜBINGEN, Deutschland, 5. März 2015  Die ... das deutsche biopharmazeutische Unternehmen CureVac geben heute ... (52 Millionen US-Dollar) in CureVac investiert. CureVac ... angewandten Messenger-RNA (mRNA). Auf Basis dieses Moleküls ... von Krankheiten und zum Schutz vor Infektionskrankheiten. ...
(Date:3/5/2015)... WHIPPANY, N.J. , March 5, 2015 ... million dollars to the Conquer Cancer Foundation of the ... a cutting edge health information technology platform designed to ... people living with cancer.  "Bayer is ... in their efforts to leverage Big Data to help ...
Breaking Medicine Technology:Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3
... , JERUSALEM , ... TEVA ) announced today the availability of new resources to ... designed to deliver Teva’s TEV-TROPIN® [somatropin (rDNA origin) for injection] ... failure due to inadequate secretion of normal endogenous growth hormone. ...
... Feb. 2 HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA), ... care program in eastern Ohio and northern West ... 30-day supply of more than 300 generic prescription medications for only ... program for as low as $83 a month, this ...
Cached Medicine Technology:Teva's Needle-Free Tjet(R) Device Takes a Kid-Friendly Approach to Growth Hormone Deficiency Treatment 2Teva's Needle-Free Tjet(R) Device Takes a Kid-Friendly Approach to Growth Hormone Deficiency Treatment 3Teva's Needle-Free Tjet(R) Device Takes a Kid-Friendly Approach to Growth Hormone Deficiency Treatment 4Teva's Needle-Free Tjet(R) Device Takes a Kid-Friendly Approach to Growth Hormone Deficiency Treatment 5Teva's Needle-Free Tjet(R) Device Takes a Kid-Friendly Approach to Growth Hormone Deficiency Treatment 6HealthWarehouse.com and PrimaryCareOne Form Partnership to Provide Low Cost Prescription Medications to Patients 2HealthWarehouse.com and PrimaryCareOne Form Partnership to Provide Low Cost Prescription Medications to Patients 3HealthWarehouse.com and PrimaryCareOne Form Partnership to Provide Low Cost Prescription Medications to Patients 4
(Date:3/6/2015)... 2015 Johnson & Johnson and Ethicon ... March 5, 2015 in Superior Court in the State ... a jury of 12 awarded Mrs. Perry $700,000 in ... with an Ethicon TVT Abbrevo plastic sling for stress ... women also awarded $5 million in punitive damages. , ...
(Date:3/6/2015)... 06, 2015 Jvion, the Atlanta-based ... of a Clostridium Difficile (C Diff) predictive use ... Diff use case is the latest in a ... acquired infections, chronic conditions, and individual illnesses. Using ... Diff solution flags at risk individuals to help ...
(Date:3/6/2015)... March 06, 2015 In a new study ... mesothelioma patients reported that shoulder pain was their first mesothelioma ... its website. Click here to read it now. ... the medical records of 49 mesothelioma patients between ... that it was shoulder pain that first prompted them to ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 FCPX developers ... from Pixel Film Studios. , “Pro3rd Hue is a lower ... Austin, CEO of Pixel Film Studios. “Blurring the line between ... , Pro3rd Hue is a set of 30 customizable lower ... X. With Pro3rd Hue, FCPX users can complement any design ...
(Date:3/6/2015)... 2015 Fluid Running® Owner, Jennifer Conroyd, ... the Fluid Running® method 3 years ago ... marathon. She hit upon the trifecta of combining matched-bpm ... a maximum-resistance, deep water running technique. She not only ... water running workout that made the experience both enjoyable ...
Breaking Medicine News(10 mins):Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Jvion Predicts Patients at Risk of C Difficile Infection to Reduce Risk and Save Lives 2Health News:New Report Reveals Shoulder Pain Could Signal Early Mesothelioma, According to Surviving Mesothelioma 2Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3
... was recently introduced at the Summer American ... for the treatment of mild-to-moderate atopic dermatitis ... LLC, the marketers of Locoid Lipocream (hydrocortisone ... corticosteroids, recently launched the new product to ...
... AIDS experts at Johns Hopkins say they have compelling evidence ... decades show extremely low levels of the virus in their ... even without treatment, probably do so because of the strength ... of HIV that infected them in the first place. ...
... INC., announced today,that the wireless version of its ... Drug Administration (FDA) 510(k) clearance., (Logo: ... MR Infusion System enables the clinician to,control a ... from both inside and outside the scan room. ...
... Inc.,s parent,company, Team Finance LLC (the "Company") today ... 2008., The Company previously announced the decision ... substantially completed the disposal,of this business line during ... accounting guidance, the results of the anesthesia management,business ...
... Prevent,Another Blood Crisis, Allow More New Yorkers To Give, ... NEW YORK, Aug. 11 With New York ... City Councilman Eric Gioia,(D-Queens), Chairman of the City Council ... Blood Center called for city,aid in expanding the successful ...
... 11 /Xinhua-PRNewswire-FirstCall/ -- China Medical,Technologies, Inc. (the "Company") ... to offer, subject to market and other conditions, ... due 2013 and,American Depositary Shares, or ADSs, which ... the notes offering pursuant to ADS,issuance and repurchase ...
Cached Medicine News:Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 2Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 3Health News:Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1% 4Health News:Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs 2Health News:Rare case explains why some infected with HIV remain symptom free without antiretroviral drugs 3Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 2Health News:MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System 3Health News:Team Finance LLC Announces Second Quarter 2008 Results 2Health News:Team Finance LLC Announces Second Quarter 2008 Results 3Health News:Team Finance LLC Announces Second Quarter 2008 Results 4Health News:Team Finance LLC Announces Second Quarter 2008 Results 5Health News:Team Finance LLC Announces Second Quarter 2008 Results 6Health News:Team Finance LLC Announces Second Quarter 2008 Results 7Health News:Team Finance LLC Announces Second Quarter 2008 Results 8Health News:Gioia & New York Blood Center Call for City Aid in Expansion of Mobile Blood Donor Coach Program 2Health News:Gioia & New York Blood Center Call for City Aid in Expansion of Mobile Blood Donor Coach Program 3Health News:China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements 2Health News:China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements 3Health News:China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements 4
Bravo Vacuum Pump Accessories Kit (One canister, one lid, one "O" ring tube, one tubing set)...
Bravo pH capsule with delivery system....
Buffer solution is needed to calibrate pH catheters. The specific chloride ion concentration in the Medtronic buffers is required for proper function of your Medtronic pH measurement system. Buffer s...
Buffer solution is needed to calibrate pH catheters. The specific chloride ion concentration in the Medtronic buffers is required for proper function of your Medtronic pH measurement system. Buffer s...
Medicine Products: